Table 1.
FDA approved medications for the treatment of bipolar disorder and their approved indications
| FDA approved agents for management of bipolar disorder as of December 2006
| |||||
|---|---|---|---|---|---|
| Mania | Mixed episodes | With or without psychotic features | Maintenance | Bipolar depression | |
| Lithium (Eskalith®, Lithobid®) | X | X | |||
| Valproate (Depakote®) | X | ||||
| Divalproex ER (Depakote ER®) | X | X | X | ||
| Carbamazepine ER (Equetro®) | X | X | |||
| Chlorpromazine (Thorazine®) | X | ||||
| Olanzapine (Zyprexa®) | X | X | X | X | |
| Risperidone (Risperdal®) | X | X | X | ||
| Quetiapine (Seroquel®) | X | X | |||
| Ziprasidone (Geodon®) | X | X | X | ||
| Aripiprazole (Abilify®) | X | X | X | X | |
| Lamotrigine (Lamictal®) | X | ||||
| Olanzapine/Fluoxetine (Symbyax®) | X | ||||